Raymond James Financial’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.2M Buy
311,986
+13,159
+4% +$727K 0.01% 1481
2025
Q1
$14.5M Sell
298,827
-4,486
-1% -$217K 0.01% 1535
2024
Q4
$11.7M Buy
+303,313
New +$11.7M ﹤0.01% 1723